HSBC Holdings
NTLA icon

HSBC Holdings’s Intellia Therapeutics NTLA Stock Holding History

HSBC Holdings’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
59,687
+11,428
+24% +$160K ﹤0.01% 1945
2026
Q1 		$614K Sell
48,259
-2,687
-5% -$34.2K ﹤0.01% 2125
2025
Q4 		$464K Sell
50,946
-3,617
-7% -$49.8K ﹤0.01% 2354
2025
Q3 		$904K Buy
54,563
+2,572
+5% +$31.7K ﹤0.01% 1839
2025
Q2 		$494K Buy
51,991
+3,057
+6% +$25.1K ﹤0.01% 2163
2025
Q1 		$343K Sell
48,934
-2,602
-5% -$26.3K ﹤0.01% 2296
2024
Q4 		$601K Buy
51,536
+16,569
+47% +$259K ﹤0.01% 2070
2024
Q3 		$722K Sell
34,967
-1,664
-5% -$38.4K ﹤0.01% 1836
2024
Q2 		$813K Buy
36,631
+2,067
+6% +$49.2K ﹤0.01% 1756
2024
Q1 		$951K Buy
34,564
+14,284
+70% +$397K ﹤0.01% 1798
2023
Q4 		$624K Buy
20,280
+152
+0.8% +$4.37K ﹤0.01% 1960
2023
Q3 		$635K Buy
+20,128
New +$781K ﹤0.01% 1893
2023
Q2 		– Sell
-21,571
Closed -$797K – 2686
2023
Q1 		$797K Buy
21,571
+13,075
+154% +$513K ﹤0.01% 1871
2022
Q4 		$292K Buy
+8,496
New +$404K ﹤0.01% 2572
2020
Q4 		– Sell
-23,091
Closed -$477K – 3107
2020
Q3 		$477K Buy
23,091
+3,022
+15% +$63K ﹤0.01% 1977
2020
Q2 		$422K Sell
20,069
-1,769
-8% -$30.1K ﹤0.01% 1938
2020
Q1 		$261K Buy
+21,838
New +$294K ﹤0.01% 2133

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

HSBC Holdings's NTLA Position: Q2 2026 in Review

HSBC Holdings increased its Intellia Therapeutics (NTLA) stake by 24% in Q2 2026, buying an estimated $160K and bringing the position to 59,687 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1945.

HSBC Holdings first reported a position in NTLA in Q1 2020 and has held it in 17 quarters since. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • HSBC Holdings held 59,687 shares of Intellia Therapeutics worth $1M as of Q2 2026.
  • HSBC Holdings bought 11,428 Intellia Therapeutics shares in Q2 2026, an estimated $160K.
  • Intellia Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1945 holding.
  • HSBC Holdings first reported a position in Intellia Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.